Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy (Q58180699)

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Influenza virus neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

The potential impact of neuraminidase inhibitor resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Influenza-virus-induced signaling cascades: targets for antiviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

MEK inhibition impairs influenza B virus propagation without emergence of resistant variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Protein kinases--the major drug targets of the twenty-first century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Caspase 3 activation is essential for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Caspases disrupt the nuclear-cytoplasmic barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

NF-kappaB signaling differentially regulates influenza virus RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

The effects of antipyretics on influenza virus encephalitis in mice and chicks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

Arbidol: a broad-spectrum antiviral compound that blocks viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161

A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP161